Results 11 to 20 of about 42,346 (181)

NLRP3 controls Trypanosoma cruzi infection through a caspase-1-dependent IL-1R-independent NO production. [PDF]

open access: yesPLoS Neglected Tropical Diseases, 2013
Trypanosoma cruzi (T. cruzi) is an intracellular protozoan parasite and the etiological agent of Chagas disease, a chronic infectious illness that affects millions of people worldwide. Although the role of TLR and Nod1 in the control of T.
Virginia M Gonçalves   +8 more
doaj   +1 more source

Antibody Repertoires Identify β-Tubulin as a Host Protective Parasite Antigen in Mice Infected With Trypanosoma cruzi

open access: yesFrontiers in Immunology, 2018
Few studies investigate the major protein antigens targeted by the antibody diversity of infected mice with Trypanosoma cruzi. To detect global IgG antibody specificities, sera from infected mice were immunoblotted against whole T. cruzi extracts.
Fabricio Montalvão   +15 more
doaj   +1 more source

Multilocus sequence typing (MLST) for lineage assignment and high resolution diversity studies in Trypanosoma cruzi. [PDF]

open access: yes, 2011
BACKGROUND: Multilocus sequence typing (MLST) is a powerful and highly discriminatory method for analysing pathogen population structure and epidemiology. Trypanosoma cruzi, the protozoan agent of American trypanosomiasis (Chagas disease), has remarkable
Michael A. Miles   +61 more
core   +1 more source

Multiple mitochondrial introgression events and heteroplasmy in trypanosoma cruzi revealed by maxicircle MLST and next generation sequencing. [PDF]

open access: yes, 2012
BACKGROUND: Mitochondrial DNA is a valuable taxonomic marker due to its relatively fast rate of evolution. In Trypanosoma cruzi, the causative agent of Chagas disease, the mitochondrial genome has a unique structural organization consisting of 20-50 ...
Andersson, B.   +61 more
core   +1 more source

Xanthine Analogs Suppress Trypanosoma cruzi Infection In Vitro Using PDEs as Targets

open access: yesMicrobiology Research, 2022
Trypanosoma cruzi (T. cruzi), the causative agent of Chagas disease, has infected 6 million people, putting 70 million people at risk worldwide. Presently, very limited drugs are available, and these have severe side effects.
Amita R. Banga   +9 more
doaj   +1 more source

Detection of Trypanosoma cruzi and Trypanosoma rangeli infection in triatomine vectors by amplification of the histone H2A/SIRE and the sno-RNA-C11 genes Detecção da infecção por Trypanosoma cruzi e Trypanosoma rangeli em vetores triatomíneos através da amplificação dos gens de histona H2A/SIRE e sno-RNA-C11

open access: yesRevista do Instituto de Medicina Tropical de São Paulo, 2007
Trypanosoma rangeli is non pathogenic for humans but of important medical and epidemiological interest because it shares vertebrate hosts, insect vectors, reservoirs and geographic areas with T. cruzi, the etiological agent of Chagas disease.
Paula Ximena Pavia   +4 more
doaj   +1 more source

Trypanosoma cruzi iron superoxide dismutases: insights from phylogenetics to chemotherapeutic target assessment

open access: yesParasites & Vectors, 2022
Background Components of the antioxidant defense system in Trypanosoma cruzi are potential targets for new drug development. Superoxide dismutases (SODs) constitute key components of antioxidant defense systems, removing excess superoxide anions by ...
Jéssica Hickson   +10 more
doaj   +1 more source

NFATc1 mediates Toll-like receptor-independent innate immune responses during Trypanosoma cruzi infection.

open access: yesPLoS Pathogens, 2009
Host defense against the intracellular protozoan parasite Trypanosoma cruzi depends on Toll-like receptor (TLR)-dependent innate immune responses. Recent studies also suggest the presence of TLR-independent responses to several microorganisms, such as ...
Hisako Kayama   +11 more
doaj   +1 more source

Immunocytochemical identification of leishmania and Trypanosoma cruzi amastigotes in situ with homologous and heterologous polyclonal antibodies

open access: yesRevista da Sociedade Brasileira de Medicina Tropical, 1991
The unlabelled antibody peroxidase-antiperoxidase method was used to study the immunocytochemical properties of Leishmania and Trypanosoma cruzi amastigotes in situ after tissues had been submitted to different fixation procedures. Antisera were obtained
A.J.A. Barbosa   +5 more
doaj   +3 more sources

Transcriptome Remodeling in Trypanosoma cruzi and Human Cells during Intracellular Infection. [PDF]

open access: yesPLoS Pathogens, 2016
Intracellular colonization and persistent infection by the kinetoplastid protozoan parasite, Trypanosoma cruzi, underlie the pathogenesis of human Chagas disease. To obtain global insights into the T.
Yuan Li   +11 more
doaj   +1 more source

Home - About - Disclaimer - Privacy